The company received gross proceeds of approximately US$1.7 million and net proceeds,
IntoCell will provide proprietary drug-linker technologies using their Ortho-Hydroxy Protected Aryl Sulfate
AMI to become part of Enpro’s Sealing Technologies Segment
Sirius JV will be owned 51% by Sirius and 49% by Adani
This combination aims to offer an effective tool to manage symptoms of nausea and vomiting during pregnancy
Furthering cell therapy ambition across oncology and autoimmune diseases
Clariant Healthcare highlighted Vitipure Meglumine LEX and VitiPure Superior at the recently concluded CPhI India
Lacosamide is indicated to treat partial-onset seizures
Darunavir is a protease inhibitor antiviral medicine that prevents Human Immunodeficiency Virus (HIV-1) from multiplying in the body
Subscribe To Our Newsletter & Stay Updated